Fingertip Pulse Oximeter Clinical Test
This study has been completed.
Sponsor:
Andon Health Co., Ltd
Information provided by (Responsible Party):
Andon Health Co., Ltd
ClinicalTrials.gov Identifier:
NCT01605955
First received: May 23, 2012
Last updated: NA
Last verified: April 2012
History: No changes posted
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to validate the SpO2 accuracy of pulse oximeter equipment in comparison to "gold-standard" measurements of blood SaO2 by a CO-oximeter
| Condition |
|---|
|
SPO2 |
| Study Type: | Observational |
| Study Design: | Time Perspective: Prospective |
Further study details as provided by Andon Health Co., Ltd:
| Enrollment: | 10 |
| Study Start Date: | November 2011 |
| Study Completion Date: | December 2011 |
| Groups/Cohorts |
|---|
|
Fingertip Pulse Oximeter
SPO2 measurement range: 70%-99%
|
|
CO-oximeter
SaO2 measurement range: 70%-99%
|
Eligibility| Ages Eligible for Study: | 25 Years to 32 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Non-Probability Sample |
Study Population
healthy volunteers who consent to induced hypoxia and arterial blood sampling as part of the experimental procedure
Criteria
Inclusion Criteria:
- Subjects participate in the study on a voluntary basis
- All subjects should be in good health at the time of the study. Unless specified otherwise in the protocol, the following values could be applied: COHb<3 %, MetHb<2 %, ctHb>10 g/dl;
- Inclusion criteria should serve the purpose of the study
Exclusion Criteria:
- Smokers or individuals exposed to high levels of carbon monoxide that result in elevated carboxyhaemoglobin levels, unless specific dyshaemoglobins are called for in the study protocol.
- Individuals subject to conditions that result in elevated levels of methaemoglobin, unless specific dyshaemoglobins are called for in the study protocol.
- Subjects who would be placed at undue medical risk associated with any procedures called for in the protocol (e.g. arterial cannulation or hypoxia).
- Age: young person and that of more than 50 years old.
Contacts and Locations
No Contacts or Locations Provided
More Information
No publications provided
| Responsible Party: | Andon Health Co., Ltd |
| ClinicalTrials.gov Identifier: | NCT01605955 History of Changes |
| Other Study ID Numbers: | AndonHealth8 |
| Study First Received: | May 23, 2012 |
| Last Updated: | May 23, 2012 |
| Health Authority: | China: Food and Drug Administration |
Keywords provided by Andon Health Co., Ltd:
|
SPO2 |
ClinicalTrials.gov processed this record on May 19, 2013